Expert Warns of Potential Brain Starvation With Rapid Weight Loss on GLP-1 Drugs
A neuroscientist highlights the risks of severe caloric restriction, emphasizing the brain's high energy demands.
Rapid weight loss facilitated by popular GLP-1 medications, such as Ozempic and Wegovy, may lead to the brain being deprived of essential energy and nutrients, according to Dr. Tommy Wood, a professor of pediatrics and neuroscience at the University of Washington.
Wood explained that the brain is the body's most energy-intensive organ, and its structural integrity, or "brain reserve," is closely linked to the body's energy availability. He noted that while obesity and related metabolic conditions can negatively impact brain health by damaging blood vessels and contributing to insulin resistance, potentially making GLP-1 drugs beneficial in such cases, extreme caloric restriction presents its own set of risks.
"The brain is really energy-hungry, and it will decrease its size if it’s not getting enough energy," Wood stated. He likened the situation to studies on marathon runners, where the brain's white matter was observed to shrink during prolonged energy depletion, though it recovered with rest and refueling. He warned that chronic under-eating associated with these weight-loss drugs could lead the brain to consume its own tissue.
Concerns also extend to muscle quality. Wood clarified that initial lean mass loss may involve fat within muscles, potentially improving muscle quality without necessarily weakening individuals. However, he cautioned that prolonged and drastic reductions in food intake can deprive the central nervous system of crucial nutrients like omega-3 fats, iron, and protein.
To mitigate these risks, Wood recommends incorporating resistance training into weight-loss regimens at least twice a week. This practice can help maintain muscle mass and stimulate brain growth factors. Additionally, ensuring sufficient intake of key "neuro-nutrients," including B vitamins (B12, folate, B6), vitamin D, iron, and omega-3 fatty acids, is vital for preventing long-term cognitive impairment. Wood advised that while these medications can be beneficial, users must ensure they do not restrict calories to an extent that compromises the brain's essential needs.